Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.87 USD | -3.92% | 0.00% | -38.77% |
15/05 | HC Wainwright Adjusts Fennec Pharmaceuticals Price Target to $15 From $18, Maintains Buy Rating | MT |
14/05 | Transcript : Fennec Pharmaceuticals Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-38.77% | 20Cr | |
+8.92% | 11TCr | |
+10.48% | 10TCr | |
-1.83% | 2.26TCr | |
-6.45% | 2.25TCr | |
-10.39% | 1.8TCr | |
-42.36% | 1.65TCr | |
-14.45% | 1.58TCr | |
+3.76% | 1.35TCr | |
+28.94% | 1.1TCr |
- Stock Market
- Equities
- FENC Stock
- News Fennec Pharmaceuticals Inc.
- Fennec Pharmaceuticals Swings to Q1 Profit on Higher Sales, Licensing Revenue